LustGarden Foundation for Pancreatic Cancer Research

Pancreatic Cancer Research

As the largest private funder of pancreatic cancer research, we are relentlessly focused on improving patient outcomes and we are making progress every day. Thanks to separate funding to support administrative expenses, 100 percent of every donation goes directly to research.

Navigating Pancreatic Cancer

We are here to empower you to ask bold questions, seek out the best treatment options, and face the unique challenges of pancreatic cancer head-on. We want to give you the resources and information you need to make informed decisions that are best for you.

Patient Checklist

Checklist

August 1, 2018 ladmin

As overwhelming as a pancreatic cancer diagnosis is, it is important to act quickly and put a treatment plan into place. Treatment should ideally begin within one month after you receive your diagnosis. Understand your disease. Thoroughly understand what stage of pancreatic cancer you have and inquire about having your blood and tumor genetically sequenced. […]

Research

Clinical Trials Finder

July 30, 2018 ladmin

If you have been diagnosed with pancreatic cancer, a clinical trial may be your best treatment option. Many clinical trials are underway for patients in all stages of the disease and may involve new combinations of currently available drugs or new drugs that have worked in other cancers. No matter where you are in your journey, we encourage you to learn more about clinical trials.

Lets Win! Pancreatic Cancer

Let’s Win! Pancreatic Cancer

July 20, 2018 ladmin

LET’S WIN! Pancreatic Cancer A Dynamic Way to Share Information Recognizing that there is an urgent need for patients to communicate amongst themselves and with the medical community about potentially life-changing treatments and clinical trials, we are proud to be affiliated with Let’s Win. Let’s Win is an interactive online community where patients and families […]

Pancreatic Cancer Connections

July 7, 2018 ladmin

Pancreatic Cancer Connections is online social community that provides a safe space for pancreatic cancer patients and their loved ones to share their experiences, get valuable coping resources, and support one another. Patients interact with others who are facing a pancreatic cancer and can post questions to the board or message other members privately. This community forum is a valuable resource for patients, caregivers, and their loved ones to refer to at various stages of their treatment and recovery.

Patients and loved ones can sign up for Pancreatic Cancer Connections at no cost and will be welcomed into an engaging and supportive community to discuss topics including treatment options, nutrition, and coping with the disease. Pancreatic Cancer Connections is hosted by Inspire, a leading healthcare social network that connects more than 1,000,000 patients and caregivers.

Lustgarten News

View All Articles

Nearly $1 Million Raised for Research!

Thank You, Long Island!

Our Long Island Walk was a huge success, and we are incredibly grateful to our presenting sponsor, Northwell Health, and all of the walkers, team members, researchers, volunteers, speakers and other sponsors who shared this day of hope with us. Because of your support, we had one of our largest crowds to date, welcoming 7,000 participants, including many walkers who have been with us since our first walk in 2001 and family members who have lost loved ones to this disease but who are more committed than ever to joining us on our journey toward a cure.

2019 Long Island Walk Charles F. DolanWe are honored that our founder, Charles Dolan, addressed the crowd with his heartfelt speech about how proud Marc Lustgarten would be to witness the breakthroughs made in treating and detecting this disease. The most inspiring part of the walk was seeing the more than 20 survivors who participated in our ribbon-cutting ceremony. They shared their stories, celebrated with their families, and served as a powerful example of how much progress we are making through research.

Thanks to your generosity, we are well on our way toward our $1 million goal. We encourage you to continue fundraising, as your page will stay open through the rest of the year. We look forward to seeing you at the Long Island Walk’s 20th anniversary next fall!

View all walk photos.

 

Related Topics:

Watch News12’s report on the walk.
Read Newsday’s article about the walk.

 

Learn More

Pancreatic Cancer Meeting Highlights

AACR Highlights: Monday, September 9

Cancer cells divide uncontrollably resulting in a flood of new tumor cells and this uncontrolled metabolic wave requires energy.

But metabolism is altered in pancreatic cancer and scientists are trying to understand the molecular underpinnings of the nutrients of choice for various cell types. These new insights into cancer metabolism kicked off the third and final day of plenary sessions at the AACR special conference on pancreatic cancer, bringing together the best minds in pancreatic cancer research. Also on the docket: new model systems, animals and beyond. Scientists are using genetically engineered mouse models that closely recapitulate human pancreatic cancer as well as organoids, small three-dimensional tumors that are grown right from the cells of patient’s tumors. Organoids in particular are potentially bringing us one step closer to personalized medicine for pancreatic cancer patients.

 

Learn More

Possible drug target for pancreatitis

 Pancreatitis is an inflammation of the pancreas that accounts for 275,000 hospitalizations in the United States annually. Patients who suffer from hereditary pancreatitis have a 40 to 50 percent lifetime risk of developing pancreatic cancer. Dannielle Engle, a former Cold Spring Harbor Laboratory (CSHL) Cancer Center postdoctoral fellow who was recently appointed Assistant Professor at Salk Institute, studies the progression of pancreatitis to pancreatic cancer. She has focused on a potentially powerful biomarker, a chemical structure created by complex sugar molecules called CA19-9, since CA19-9 is elevated in patients with pancreatitis and pancreatic cancer.

Learn More

Pancreatic Cancer News

View All Articles

Yale scientists help immune system find hidden cancer cells

14. 10. 19 ladmin

Cancer cells are masters at avoiding detection, but a new system developed by Yale scientists can make them stand out from the crowd and help the immune system spot and eliminate tumors that other forms of immunotherapies might miss, the researchers report Oct. 14 in the journal Nature Immunology. The new system reduced or eliminated […]

Rafael Pharmaceuticals Reaches Milestone of 100 Patients Enrolled in Pivotal Phase 3 Trial (AVENGER 500) of CPI-613®️ (devimistat) for Patients with Metastatic Pancreatic Cancer

8. 10. 19 ladmin

 Rafael Pharmaceuticals, Inc. (“Rafael” or the “Company”), a leader in the growing field of cancer metabolism-based therapeutics, today announced that it has enrolled 100 patients in its pivotal Phase 3 clinical trial for metastatic pancreatic cancer (AVENGER 500). The multicenter, open-label, randomized trial is evaluating the efficacy and safety of Rafael’s lead compound CPI-613®️ (devimistat) in […]

Study: Innovative pancreatic cancer treatment may rev up immune system

8. 10. 19 ladmin

A University of Rochester Wilmot Cancer Institute research team reports that combining a type of radiation therapy with immunotherapy not only cures pancreatic cancer in mice, but appears to reprogram the immune system to create an “immune memory” in the same way that a vaccine keeps the flu away. The result is that the combination […]

Cancer Is Still Beating Us—We Need a New Start

4. 10. 19 ladmin

I have been studying and treating cancer for 35 years, and here’s what I know about the progress made in that time: There has been far less than it appears. Despite some advances, the treatments for most kinds of cancer continue to be too painful, too damaging, too expensive and too ineffective. The same three […]

Response rate to albumin-bound paclitaxel plus gemcitabine plus cisplatin treatment among patients with advanced pancreatic cancer: A phase 1b/2 pilot clinical tria

3. 10. 19 ladmin

 Adding a drug that targets a molecular vulnerability in pancreatic cancer could provide substantial benefit to patients, according to a clinical trial study by the HonorHealth Research Institute and the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, in conjunction with the Pancreatic Cancer Research Team and Cancer Research And Biostatistics. Published […]

Drug Trio Improves Odds Against Advanced Pancreatic Cancer

3. 10. 19 ladmin

A three-drug chemo cocktail appears to shrink tumors and improve survivorship among pancreatic cancer patients, a new, small study shows. Tumors substantially shrank for just over 71% of patients treated with a three-drug regimen of nab-paclitaxel, gemcitabine and platinum-based cisplatin, the researchers found. Further, 16 patients (64%) out of the 25 treated were still alive […]

Fungal Invasion of Pancreas Creates Cancer Risk

2. 10. 19 ladmin

Certain fungi move from the gut to the pancreas, expand their population more than a thousand-fold, and encourage pancreatic cancer growth, a new study finds. Published online in Nature October 2, the study is the first to offer strong evidence that the mycobiome—the local mix of fungal species in the pancreas—can trigger changes that turn normal cells into pancreatic […]

Why Can’t We Stop Pancreatic Cancer?

23. 9. 19 ladmin

Pancreatic cancer, which will be diagnosed in about 56,770 people in the United States this year, is the only cancer with a rising mortality rate through 2014, although five-year survival has begun to inch up, from 8 percent to 9 percent by 2016. It remains the nation’s third leading cause of cancer deaths, after cancers […]

A compound may improve pancreatic cancer survival rate, scientists find

19. 9. 19 ladmin

Scientists have discovered a compound could help slow down pancreatic cancer by targeting proteins that promote metastatic cells. Researchers at Johns Hopkins Medicine found that the compound, 4-HAP, reduced tumors in mice and could improve survival for pancreatic cancer patients. According to the National Cancer Institute, 73,554 people in the U.S. have pancreatic cancer and […]

Join Us

Get Involved Today

Get inspired and connect with patients, survivors and loved ones who are all on the same journey.

Back to Top